Schizophrenia Symptom Management
- Male or female
- 13 - 65 years old
- Have a diagnosis of schizophrenia
- Have a history of at least 1 relapse in the last 2 years
This study will evaluate the long term safety and tolerability of an injectable investigational medication for the treatment of chronic schizophrenia symptoms. All study-related visits, exams, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.
To find out more click here